Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Schwenger

Showing results (161-170 of 376) with videos related to

Pageof 38
Sort By:
Frontiers in Immunology|December 13, 2019
Kidneys From Elderly Deceased Donors-Is 70 the New 60?Fabian Echterdiek, Vedat Schwenger, Bernd Döhler, et al.
Clinical Transplantation|November 15, 2006
Antifibrotic actions of mycophenolic acidChristian Morath, Vedat Schwenger, Jörg Beimler, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|July 28, 2018
In nonalcoholic fatty liver disease, Roux-en-Y gastric bypass improves liver histology while persistent disease is associated with lower improvements in waist circumference and glycemic controlKatherine J P Schwenger, Sandra E Fischer, Timothy Jackson, et al.
Clinical Transplantation|February 11, 2022
Outcome of kidney transplantations from ≥65-year-old deceased donors with acute kidney injuryFabian Echterdiek, Daniel Kitterer, Jürgen Dippon, et al.
Clinical Transplantation|June 6, 2017
Switch to an everolimus-facilitated cyclosporine A sparing immunosuppression improves glycemic control in selected kidney transplant recipientsFlorian Kälble, Jörg Seckinger, Matthias Schaier, et al.
Clinical Nephrology|October 30, 2009
Optimal blood pressure control versus additional immunosuppressive therapy in idiopathic membranous nephropathy - a retrospective analysisR Dikow, P Quentmeier, V Schwenger, et al.
Nephron|September 10, 2002
Cyclosporin A toxicity of the renal allograft--a late complication and potentially reversibleClaudia Sommerer, Okaf Hergesell, Anna-Maria Nahm, et al.
Case Reports in Medicine|January 29, 2011
Hepatic and renal failure after anterior myocardial infarction induced apical ventricular septal defectDirk Lossnitzer, Vedat Schwenger, Stephanie Lehrke, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 26, 2019
A follow-up report on potential drug interactions with clementines: Two single case experiments show no effect on CYP3A-dependent midazolam clearanceNicolas Hohmann, Gerd Mikus, Walter Emil Haefeli, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 26, 2015
High interpatient variability in response to mycophenolic acid maintenance therapy in patients with ANCA-associated vasculitisMatthias Schaier, Christian Scholl, Dominik Scharpf, et al.
Pageof 38

Showing results (161-170 of 376) with videos related to

Sort By:
Pageof 38
Frontiers in Immunology|December 13, 2019
Kidneys From Elderly Deceased Donors-Is 70 the New 60?Fabian Echterdiek, Vedat Schwenger, Bernd Döhler, et al.
Clinical Transplantation|November 15, 2006
Antifibrotic actions of mycophenolic acidChristian Morath, Vedat Schwenger, Jörg Beimler, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|July 28, 2018
In nonalcoholic fatty liver disease, Roux-en-Y gastric bypass improves liver histology while persistent disease is associated with lower improvements in waist circumference and glycemic controlKatherine J P Schwenger, Sandra E Fischer, Timothy Jackson, et al.
Clinical Transplantation|February 11, 2022
Outcome of kidney transplantations from ≥65-year-old deceased donors with acute kidney injuryFabian Echterdiek, Daniel Kitterer, Jürgen Dippon, et al.
Clinical Transplantation|June 6, 2017
Switch to an everolimus-facilitated cyclosporine A sparing immunosuppression improves glycemic control in selected kidney transplant recipientsFlorian Kälble, Jörg Seckinger, Matthias Schaier, et al.
Clinical Nephrology|October 30, 2009
Optimal blood pressure control versus additional immunosuppressive therapy in idiopathic membranous nephropathy - a retrospective analysisR Dikow, P Quentmeier, V Schwenger, et al.
Nephron|September 10, 2002
Cyclosporin A toxicity of the renal allograft--a late complication and potentially reversibleClaudia Sommerer, Okaf Hergesell, Anna-Maria Nahm, et al.
Case Reports in Medicine|January 29, 2011
Hepatic and renal failure after anterior myocardial infarction induced apical ventricular septal defectDirk Lossnitzer, Vedat Schwenger, Stephanie Lehrke, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 26, 2019
A follow-up report on potential drug interactions with clementines: Two single case experiments show no effect on CYP3A-dependent midazolam clearanceNicolas Hohmann, Gerd Mikus, Walter Emil Haefeli, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 26, 2015
High interpatient variability in response to mycophenolic acid maintenance therapy in patients with ANCA-associated vasculitisMatthias Schaier, Christian Scholl, Dominik Scharpf, et al.
Pageof 38